RhumbLine Advisers’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,112
| Closed | -$2.46K | – | 4392 |
|
|
2023
Q2 | $2.46K | Buy |
+1,112
| New | +$2.46K | ﹤0.01% | 4187 |
|
|
2022
Q2 | – | Sell |
-44,588
| Closed | -$132K | – | 3293 |
|
|
2022
Q1 | $132K | Sell |
44,588
-7,567
| -15% | -$22.4K | ﹤0.01% | 2842 |
|
|
2021
Q4 | $234K | Sell |
52,155
-731
| -1% | -$3.28K | ﹤0.01% | 2789 |
|
|
2021
Q3 | $257K | Buy |
52,886
+2,150
| +4% | +$10.4K | ﹤0.01% | 2831 |
|
|
2021
Q2 | $346K | Sell |
50,736
-3,491
| -6% | -$23.8K | ﹤0.01% | 2728 |
|
|
2021
Q1 | $383K | Sell |
54,227
-1,840
| -3% | -$13K | ﹤0.01% | 2609 |
|
|
2020
Q4 | $351K | Buy |
56,067
+3,579
| +7% | +$22.4K | ﹤0.01% | 2601 |
|
|
2020
Q3 | $284K | Sell |
52,488
-8,585
| -14% | -$46.5K | ﹤0.01% | 2542 |
|
|
2020
Q2 | $319K | Buy |
61,073
+12,039
| +25% | +$62.9K | ﹤0.01% | 2549 |
|
|
2020
Q1 | $154K | Hold |
49,034
| – | – | ﹤0.01% | 2668 |
|
|
2019
Q4 | $198K | Buy |
49,034
+4,616
| +10% | +$18.6K | ﹤0.01% | 2754 |
|
|
2019
Q3 | $192K | Sell |
44,418
-300
| -0.7% | -$1.3K | ﹤0.01% | 2758 |
|
|
2019
Q2 | $178K | Buy |
44,718
+4,380
| +11% | +$17.4K | ﹤0.01% | 2823 |
|
|
2019
Q1 | $216K | Sell |
40,338
-860
| -2% | -$4.61K | ﹤0.01% | 2716 |
|
|
2018
Q4 | $211K | Buy |
41,198
+13,733
| +50% | +$70.3K | ﹤0.01% | 2714 |
|
|
2018
Q3 | $266K | Sell |
27,465
-2,050
| -7% | -$19.9K | ﹤0.01% | 2579 |
|
|
2018
Q2 | $301K | Buy |
29,515
+6,240
| +27% | +$63.6K | ﹤0.01% | 2533 |
|
|
2018
Q1 | $303K | Buy |
23,275
+610
| +3% | +$7.94K | ﹤0.01% | 2430 |
|
|
2017
Q4 | $406K | Sell |
22,665
-5,396
| -19% | -$96.7K | ﹤0.01% | 2322 |
|
|
2017
Q3 | $704K | Buy |
28,061
+959
| +4% | +$24.1K | ﹤0.01% | 2155 |
|
|
2017
Q2 | $653K | Buy |
27,102
+7,389
| +37% | +$178K | ﹤0.01% | 2167 |
|
|
2017
Q1 | $379K | Buy |
19,713
+2,270
| +13% | +$43.6K | ﹤0.01% | 2381 |
|
|
2016
Q4 | $269K | Buy |
17,443
+1,456
| +9% | +$22.5K | ﹤0.01% | 2540 |
|
|
2016
Q3 | $208K | Buy |
15,987
+2,195
| +16% | +$28.6K | ﹤0.01% | 2659 |
|
|
2016
Q2 | $192K | Buy |
13,792
+1,510
| +12% | +$21K | ﹤0.01% | 2762 |
|
|
2016
Q1 | $186K | Buy |
12,282
+65
| +0.5% | +$984 | ﹤0.01% | 2757 |
|
|
2015
Q4 | $232K | Buy |
12,217
+1,810
| +17% | +$34.4K | ﹤0.01% | 2716 |
|
|
2015
Q3 | $198K | Buy |
10,407
+477
| +5% | +$9.08K | ﹤0.01% | 2792 |
|
|
2015
Q2 | $256K | Buy |
+9,930
| New | +$256K | ﹤0.01% | 2758 |
|